Background Intraluminal femoropopliteal stenting enables favorable dilation and good
immediate results; however, whether this contributes to long-term patency is unclear. We …

Purpose: To report a randomized trial comparing the Legflow paclitaxel-eluting balloon
(PEB)+ Supera stenting to Supera stenting alone in patients with intermediate to long …

Purpose To investigate the long-term outcomes of nitinol stenting in femoropopliteal lesions
and to determine the factors associated with restenosis. Methods Between December 2003 …

Background Lower limb peripheral arterial disease (PAD) is a common, important
manifestation of systemic atherosclerosis. Stenoses or occlusions in the superficial femoral …

Objectives To evaluate longer‐term safety and efficacy of a single self‐expanding stent up to
20 cm in length in patients with atherosclerotic disease of the superficial femoral (SFA) and …

Background: The use of a stent in the treatment of lesions of the superficial femoral artery
(SFA) remains controversial. Although some reports have suggested that use of a nitinol …

Background: Peripheral artery disease (PAD) remains a major issue in modern societies
and affects more than 200 million people around the world. Endovascular methods have …

Purpose Advancements in the endovascular treatment of femoropopliteal atherosclerotic
lesions have led to treatment of more complex lesions, particularly long lesions. The aim of …

Peripheral artery disease (PAD) includes atherosclerosis of the aorta and lower extremities.
Affecting a large segment of the population, PAD is associated with impaired functional …

Background The performance of paclitaxel-coated balloon (PCB) or primary bare nitinol
stent (BNS) versus uncoated balloon angioplasty (UCB) for femoropopliteal artery disease …